The UK’s National Health Service (NHS) is receiving a £29bn ($39.1bn) funding boost, reflecting a 3% annual rise on current ...

Echosens and Boehringer Ingelheim have expanded their collaboration aimed at expediting progress in MASH diagnosis and care.

Antares Therapeutics has secured $177m in Series A financing round for the development of precision medicines.

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

The Scottish Medicines Consortium (SMC) has accepted Outlook Therapeutics’ Lytenava to treat wet age-related macular ...

MSD has received FDA approval for Enflonsia (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV) in neonates and ...

The EC has approved Alnylam Pharmaceuticals' Amvuttra (vutrisiran) to treat wild-type or hereditary ATTR-CM in adults.

Mosanna Therapeutics has secured $80m in a Series A funding round for advancing new nighttime nasal spray for obstructive ...

The 17 sitting members of the Advisory Committee on Immunization Practices (ACIP) will be replaced by new members chosen by ...

The EC has granted approval for a fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) plus venetoclax.

Download to gain expert insights and data-driven analysis from the ASCO 2025 Annual Meeting. This report covers key ...

YolTech has received FDA approval for its investigational new drug (IND) application for YOLT-101 to treat HeFH.